Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Agencia Inventiva
Daix, Bourgogne-Franche-Comté, Franceadinventiva.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Lanifibranor has advanced to a fully recruited Phase III trial for NASH. Odiparcil demonstrated favorable safety and efficacy in adult MPS VI patients in a completed Phase IIa study. The company maintains additional early-stage programs across fibrosis and oncology.
- Therapeutic areas
- OncologyPulmonologyRare DiseasesOtherDermatologyGastroenterology
- Modalities
- Small moleculeOral small molecule therapy
- Industry
- Biotech
02
Partnerships
Sino BiopharmHepalys Pharma Inc.AbbVie (collaboration on ABBV‑157)AbbottSolvayFournier
Beyond the preview
Go deeper on Agencia Inventiva.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Agencia Inventiva.